Who owns Atyr Pharma Inc?
- Ticker: ATYR
- CUSIP Number: 002120202
Tip: Access positions for across all investors
Analyze quarterly positions in Atyr Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Atyr Pharma stock
Who bought or sold Atyr Pharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Federated Investors | 15M | $23M | 44% | Jun 2024 |
|
| FMR | 8.9M | $17M | 100% | Mar 2024 |
|
| Logos Global Management | 3.0M | $4.7M | -3% | Jun 2024 |
|
| Vanguard Group | 2.7M | $4.1M | 0% | Jun 2024 |
|
| Tikvah Management | 2.5M | $3.8M | 0% | Jun 2024 |
|
| Checkpoint Capital | 1.9M | $3.0M | 35% | Jun 2024 |
|
| Alyeska Investment Group | 1.9M | $2.9M | 24% | Jun 2024 |
|
| Citadel Advisors | 1.9M | $2.9M | -3% | Jun 2024 |
|
| Woodline Partners | 1.7M | $2.6M | 0% | Jun 2024 |
|
| BlackRock | 1.4M | $2.2M | 2% | Jun 2024 |
|
| Renaissance Technologies | 1.3M | $2.0M | 2% | Jun 2024 |
|
| Ghost Tree Capital | 800k | $1.2M | 33% | Jun 2024 |
|
| Tang Capital Management | 671k | $1.0M | 42% | Jun 2024 |
|
| Geode Capital Management | 663k | $1.0M | 11% | Jun 2024 |
|
| GSA Capital Partners | 323k | $503k | 44% | Jun 2024 |
|
| Superstring Capital Management | 313k | $488k | 100% | Jun 2024 |
|
| State Street Corporation | 168k | $263k | 1% | Jun 2024 |
|
| Dimensional Fund Advisors | 146k | $227k | -26% | Jun 2024 |
|
| Bank of America Corporation | 117k | $183k | -25% | Jun 2024 |
|
| Millennium Management | 106k | $166k | 70% | Jun 2024 |
|
| Northern Trust | 99k | $193k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 96k | $150k | -33% | Jun 2024 |
|
| American Century Companies | 61k | $94k | 12% | Jun 2024 |
|
| Schonfeld Strategic Advisors | 39k | $61k | 90% | Jun 2024 |
|
| Main Street Financial Solutions | 35k | $67k | 100% | Mar 2024 |
|
| Farther Finance Advisors | 30k | $48k | 0% | Jun 2024 |
|
| Sanctuary Advisors | 29k | $46k | 100% | Jun 2024 |
|
| Jane Street | 29k | $44k | -54% | Jun 2024 |
|
| Virtu Financial | 28k | $44k | 100% | Jun 2024 |
|
| D.A. Davidson & Co. | 28k | $43k | 6% | Jun 2024 |
|
| Tower Research Capital | 27k | $43k | 336% | Jun 2024 |
|
| Charles Schwab Investment Management | 27k | $42k | 0% | Jun 2024 |
|
| Jpmorgan Chase & Co | 21k | $32k | -39% | Jun 2024 |
|
| UBS Group | 20k | $39k | 23% | Mar 2024 |
|
| Cubist Systematic Strategies | 17k | $26k | 40% | Jun 2024 |
|
| Prudential Financial | 16k | $31k | 5% | Mar 2024 |
|
| Royal Bank of Canada | 14k | $22k | -11% | Jun 2024 |
|
| Verition Fund Management | 13k | $20k | 100% | Jun 2024 |
|
| Actinver Wealth Management | 10k | $16k | 0% | Jun 2024 |
|
| Simplex Trading | 1.9k | $2.0k | -69% | Jun 2024 |
|
| Wells Fargo & Company | 1.5k | $2.3k | -22% | Jun 2024 |
|
| PFS Partners | 340.00 | $531.012000 | 0% | Jun 2024 |
|
| Cypress Capital | 200.00 | $312.000000 | 100% | Jun 2024 |
|
| Qube Research & Technologies | 188.00 | $294.633600 | -98% | Jun 2024 |
|
| Sachetta | 150.00 | $297.000000 | 100% | Jun 2024 |
|
| Caldwell Sutter Capital | 52.00 | $81.000400 | 0% | Jun 2024 |
|
| Strategic Investment Solutions | 8.00 | $16.000000 | 100% | Jun 2024 |
|
| Morgan Stanley | 1.00 | $2.000000 | -100% | Jun 2024 |
|
Who sold out of Atyr Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Octagon Capital Advisors | Mar 2024 | 700k | $1.4M |
| Barclays | Mar 2024 | 604k | $1.2M |
| Goldman Sachs Group | Mar 2024 | 217k | $424k |
| Marshall Wace | Mar 2024 | 159k | $309k |
| Pale Fire Capital SE | Mar 2024 | 91k | $178k |
| XTX Topco | Mar 2024 | 83k | $163k |
| Citigroup | Mar 2024 | 79k | $153k |
| Kingswood Wealth Advisors | Mar 2024 | 60k | $117k |
| Jump Financial | Mar 2024 | 50k | $97k |
| Acadian Asset Management | Mar 2024 | 45k | $87k |
| Y-Intercept | Mar 2024 | 44k | $86k |
| SG Americas Securities | Mar 2024 | 28k | $55k |
| CTC Alternative Strategies | Mar 2024 | 18k | $34k |
| Two Sigma Securities | Mar 2024 | 18k | $34k |
| Two Sigma Investments | Mar 2024 | 10k | $20k |